Works matching IS 00070920 AND DT 2023 AND VI 129 AND IP 2
Results: 18
Neighbourhood social deprivation and risk of prostate cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 335, doi. 10.1038/s41416-023-02299-7
- By:
- Publication type:
- Article
Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 366, doi. 10.1038/s41416-023-02301-2
- By:
- Publication type:
- Article
Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 374, doi. 10.1038/s41416-023-02300-3
- By:
- Publication type:
- Article
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 291, doi. 10.1038/s41416-023-02298-8
- By:
- Publication type:
- Article
Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 325, doi. 10.1038/s41416-023-02291-1
- By:
- Publication type:
- Article
Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 283, doi. 10.1038/s41416-023-02290-2
- By:
- Publication type:
- Article
Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 346, doi. 10.1038/s41416-023-02283-1
- By:
- Publication type:
- Article
Targeting metabolism by B-raf inhibitors and diclofenac restrains the viability of BRAF-mutated thyroid carcinomas with Hif-1α-mediated glycolytic phenotype.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 249, doi. 10.1038/s41416-023-02282-2
- By:
- Publication type:
- Article
Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 318, doi. 10.1038/s41416-023-02281-3
- By:
- Publication type:
- Article
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 222, doi. 10.1038/s41416-023-02266-2
- By:
- Publication type:
- Article
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 266, doi. 10.1038/s41416-023-02280-4
- By:
- Publication type:
- Article
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 309, doi. 10.1038/s41416-023-02276-0
- By:
- Publication type:
- Article
RNA modifications in cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 204, doi. 10.1038/s41416-023-02275-1
- By:
- Publication type:
- Article
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 275, doi. 10.1038/s41416-023-02269-z
- By:
- Publication type:
- Article
What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 356, doi. 10.1038/s41416-023-02268-0
- By:
- Publication type:
- Article
NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 237, doi. 10.1038/s41416-023-02278-y
- By:
- Publication type:
- Article
Six-year experience of Australia's first dedicated cancer of unknown primary clinic.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 301, doi. 10.1038/s41416-023-02254-6
- By:
- Publication type:
- Article
Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 185, doi. 10.1038/s41416-023-02245-7
- By:
- Publication type:
- Article